You are here

  • Home
  • Archive
  • Volume 82, Issue 6
  • 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

Citation Tools

Article menu

Download PDFPDF

Autoimmunity
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rodríguez-Carrio J, Burska A, Conaghan PG, et al
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
Annals of the Rheumatic Diseases 2023;82:754-762.